DXCMDexcom
$79.41+16% 1Y
$79.41
$54.8452 weeks$92.35
Growth
Is DXCM growing?
Dexcom's revenue has grown 14% a year over three years, and grown 17% a year over five, with earnings per share compounding at 41%.
+14%
Revenue growth, 3-year annual rate · Medical Devices median +13% · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +17%
Revenue growth, 5-year rate · +14% over three · the three-year rate is below the five-year rate
- Earnings per share, 3-year rate
- +41%
Earnings per share, 3-year rate · revenue +14% · earnings per share grew faster than revenue
- Years of annual history on file
- 17
Years of annual history on file · FY2009 to FY2025, as filed
Details›
- Revenue FY2021
- $2.45B
- Revenue FY2022
- $2.91B
- Revenue FY2023
- $3.62B
- Revenue FY2024
- $4.03B
- Revenue FY2025
- $4.66B
Annual income statements as filed with the SEC.
Where the revenue comes from
6 quarters, Mar 2025 to Jun 2026United States, quarter to Jun 2026from $720.6M in Mar 2025$893.5M
United States$893.5M
Non Us$208.9M
Medical Devices
The closest names by size in the same industry